Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic Study
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Status
- RECRUITING
- Phase
- PHASE3
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
- Status
- RECRUITING
- Phase
- NA
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
- Status
- RECRUITING
- Phase
- N/A
A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants
- Status
- COMPLETED
- Phase
- PHASE2
89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
- Status
- RECRUITING
- Phase
- PHASE3
Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
DESTINY Breast Respond HER2-(Ultra)Low Europe
- Status
- RECRUITING
- Phase
- N/A